https://www.selleckchem.com/pr....oducts/fluspirilene.
In addition, the current status of ACE2 as a targeted therapy for COVID‑19 is discussed in order to provide new insight into the clinical prevention and treatment of COVID‑19.Following the publication of this article and after having solicited the opinions of all the participating authors, the Editorial Office was contacted by the authors to explain that the following changes are required to the list of contributing authors on the paper. The corresponding author of the article should be changed to the first author (Gang Chen), and
Like
Comment
Share
